These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8894096)

  • 1. Gelatin microspheres: influence of preparation parameters and thermal treatment on chemico-physical and biopharmaceutical properties.
    Esposito E; Cortesi R; Nastruzzi C
    Biomaterials; 1996 Oct; 17(20):2009-20. PubMed ID: 8894096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel glycidyl methacrylated dextran (Dex-GMA)/gelatin hydrogel scaffolds containing microspheres loaded with bone morphogenetic proteins: formulation and characteristics.
    Chen FM; Zhao YM; Sun HH; Jin T; Wang QT; Zhou W; Wu ZF; Jin Y
    J Control Release; 2007 Mar; 118(1):65-77. PubMed ID: 17250921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of lipospheres as carriers for bioactive compounds.
    Cortesi R; Esposjto E; Luca G; Nastruzzi C
    Biomaterials; 2002 Jun; 23(11):2283-94. PubMed ID: 12013175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonionic surfactant structure on the drug release, formulation and physical properties of ethylcellulose microspheres.
    Thakare M; Israel B; Garner S; Ahmed H; Elder D; Capomacchia A
    Pharm Dev Technol; 2017 May; 22(3):418-425. PubMed ID: 27499352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailoring of alginate-gelatin microspheres properties for oral Ciprofloxacin-controlled release against Pseudomonas aeruginosa.
    Islan GA; Castro GR
    Drug Deliv; 2014 Dec; 21(8):615-26. PubMed ID: 24401147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and in vitro evaluation of gelatin microspheres containing an antitumour tetra-amidine.
    Nastruzzi C; Pastesini C; Cortesi R; Esposito E; Gambari R; Menegatti E
    J Microencapsul; 1994; 11(3):249-60. PubMed ID: 8064549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxprenolol-loaded bioadhesive microspheres: preparation and in vitro/in vivo characterization.
    Preda M; Leucuta SE
    J Microencapsul; 2003; 20(6):777-89. PubMed ID: 14594666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of gelatin microspheres containing lactic acid--effect of cross-linking on drug release.
    Dinarvand R; Mahmoodi S; Farboud E; Salehi M; Atyabi F
    Acta Pharm; 2005 Mar; 55(1):57-67. PubMed ID: 15907224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of process variables on particle size and viability of Bifidobacterium lactis Bb-12 in genipin-gelatin microspheres.
    Annan NT; Borza A; Moreau DL; Allan-Wojtas PM; Hansen LT
    J Microencapsul; 2007 Mar; 24(2):152-62. PubMed ID: 17454426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release of lysozyme from succinylated gelatin microspheres.
    Srinivas SS; Rao KP
    J Biomater Sci Polym Ed; 2001; 12(2):137-48. PubMed ID: 11403231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gelatin microspheres crosslinked with D,L-glyceraldehyde as a potential drug delivery system: preparation, characterisation, in vitro and in vivo studies.
    Vandelli MA; Rivasi F; Guerra P; Forni F; Arletti R
    Int J Pharm; 2001 Mar; 215(1-2):175-84. PubMed ID: 11250103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction of gelatin microspheres into an injectable calcium phosphate cement.
    Habraken WJ; de Jonge LT; Wolke JG; Yubao L; Mikos AG; Jansen JA
    J Biomed Mater Res A; 2008 Dec; 87(3):643-55. PubMed ID: 18189298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dextran cross-linked gelatin microspheres as a drug delivery system.
    Cortesi R; Esposito E; Osti M; Squarzoni G; Menegatti E; Davis SS; Nastruzzi C
    Eur J Pharm Biopharm; 1999 Mar; 47(2):153-60. PubMed ID: 10234540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
    Jelvehgari M; Atapour F; Nokhodchi A
    Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grafted thermo-responsive gelatin microspheres as delivery systems in triggered drug release.
    Curcio M; Gianfranco Spizzirri U; Iemma F; Puoci F; Cirillo G; Parisi OI; Picci N
    Eur J Pharm Biopharm; 2010 Sep; 76(1):48-55. PubMed ID: 20580821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulation and characterization of controlled release flurbiprofen loaded microspheres using beeswax as an encapsulating agent.
    Ranjha NM; Khan H; Naseem S
    J Mater Sci Mater Med; 2010 May; 21(5):1621-30. PubMed ID: 20217193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of negatively charged poly(lactic-co-glycolic acid) microspheres.
    Xu Q; Crossley A; Czernuszka J
    J Pharm Sci; 2009 Jul; 98(7):2377-89. PubMed ID: 19009589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gelatin microspheres of rifampicin cross-linked with sucrose using thermal gelation method for the treatment of tuberculosis.
    Samad A; Sultana Y; Khar RK; Chuttani K; Mishra AK
    J Microencapsul; 2009 Feb; 26(1):83-9. PubMed ID: 18608799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity of 5-fluorouracil entrapped in gelatin microspheres.
    Muvaffak A; Gürhan I; Hasirci N
    J Microencapsul; 2004 May; 21(3):293-306. PubMed ID: 15204596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.